Heme oxygenase-2 and large-conductance Ca2+-activated K + channels: Lung vascular effects of hypoxia

American Journal of Respiratory and Critical Care Medicine

Volumn 180, Issue 4, 2009, Pages 353-364

  Roth, Markus ^a   Rupp, Markus ^a   Hofmann, Simone ^a   Mittal, Manish ^a   Fuchs, Beate ^a   Sommer, Natascha ^a   Parajuli, Nirmal ^a   Quanz, Karin ^a   Schubert, Dominic ^a   Dony, Eva ^a   Schermuly, Ralph Theo ^a   Ghofrani, Hossein Ardeschir ^a   Sausbier, Ulrike ^b   Rutschmann, Katrin ^c   Wilhelm, Sarah ^c   Seeger, Werner ^a   Ruth, Peter ^b   Grimminger, Friedrich ^a   Sausbier, Matthias ^b   Weissmann, Norbert ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c DUALSYSTEMS BIOTECH AG   (Switzerland)

Author keywords

Hypoxic pulmonary vasoconstriction; Oxygen sensor; Vascular remodeling

Indexed keywords

HEME OXYGENASE 2; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNIT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; BRONCHUS MUCOSA; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; HYPOXIA; HYPOXIC LUNG VASOCONSTRICTION; LUNG ALVEOLUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; VASCULAR SMOOTH MUSCLE; WILD TYPE;

ANIMALS; ANOXIA; HEME OXYGENASE (DECYCLIZING); HYPERTENSION, PULMONARY; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; LUNG; MICE; MICROSCOPY, FLUORESCENCE; MUSCLE, SMOOTH, VASCULAR; POLYMERASE CHAIN REACTION; PULMONARY ALVEOLI; PULMONARY WEDGE PRESSURE; RNA, MESSENGER; VASOCONSTRICTION;

EID: 68849094640     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200806-848OC     Document Type: Article

References (48)

1. Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W, et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 2005;115:2811-2821.
2. Weissmann N, Grimminger F, Olschewski A, Seeger W. Hypoxic pulmonary vasoconstriction: a multifactorial response? Am J Physiol Lung Cell Mol Physiol 2001;281:L314-L317.
3. Jeffery TK, Wanstall JC. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 2001;92:1-20.
4. Weissmann N, Dietrich A, Fuchs B, Kalwa H, Ay M, Dumitrascu R, Olschewski A, Storch U, Schnitzler M, Ghofrani HA, et al. Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange. Proc Natl Acad Sci USA 2006;103:19093-19098.
5. Weissmann N, Akkayagil E, Quanz K, Schermuly RT, Ghofrani HA, Fink L, Hanze J, Rose F, Seeger W, Grimminger F. Basic features of hypoxic pulmonary vasoconstriction in mice. Respir Physiol Neurobiol 2004;139:191-202.
6. Vejlstrup NG, Dorrington KL. Intense slow hypoxic pulmonary vasoconstriction in gas-filled and liquid-filled lungs: an in vivo study in the rabbit. Acta Physiol Scand 1993;148:305-313.
7. Sartori C, Allemann Y, Trueb L, Delabays A, Nicod P, Scherrer U. Augmented vasoreactivity in adult life associated with perinatal vascular insult. Lancet 1999;353:2205-2207.
8. Williams SE, Wootton P, Mason HS, Bould J, Iles DE, Riccardi D, Peers C, Kemp PJ. Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 2004;306:2093-2097.
9. Adachi T, Ishikawa K, Hida W, Matsumoto H, Masuda T, Date F, Ogawa K, Takeda K, Furuyama K, Zhang Y, et al. Hypoxemia and blunted hypoxic ventilatory responses in mice lacking heme oxygenase-2. Biochem Biophys Res Commun 2004;320:514-522.
10. Ortega-Sáenz P, Pascual A, Gomez-Diaz R, Lopez-Barneo J. Acute oxygen sensing in heme oxygenase-2 null mice. J Gen Physiol 2006;128:405-411.
11. Kikuchi G, Yoshida T, Noguchi M. Heme oxygenase and heme degradation. Biochem Biophys Res Commun 2005;338:558-567.
12. + channels. Circ Res 2005;97:805-812.
13. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997;37:517-554.
14. Boehning D, Moon C, Sharma S, Hurt KJ, Hester LD, Ronnett GV, Shugar D, Snyder SH. Carbon monoxide neurotransmission activated by CK2 phosphorylation of heme oxygenase-2. Neuron 2003;40:129-137.
15. Ryter SW, Morse D, Choi AM. Carbon monoxide: to boldly go where NO has gone before. Sci STKE 2004;2004:RE6.
16. + channel deficiency. Proc Natl Acad Sci USA 2004;101:9474-9478.
17. Sausbier M, Arntz C, Bucurenciu I, Zhao H, Zhou XB, Sausbier U, Feil S, Kamm S, Essin K, Sailer CA, et al. Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channel-deficient mice. Circulation 2005;112:60-68.
18. Tang XD, Xu R, Reynolds MF, Garcia ML, Heinemann SH, Hoshi T. Haem can bind to and inhibit mammalian calcium-dependent Slo1 BK channels. Nature 2003;425:531-535.
19. 2+ sensor confers carbon monoxide sensitivity to Slo1 BK channels. Proc Natl Acad Sci USA 2008;105:4039-4043.
20. Dumitrascu R, Weissmann N, Ghofrani HA, Dony E, Beuerlein K, Schmidt H, Stasch JP, Gnoth MJ, Seeger W, Grimminger F, et al. Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling. Circulation 2006;113:286-295.
21. Ord JJ, Streeter EH, Roberts IS, Cranston D, Harris AL. Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer. Br J Cancer 2005;93:346-354.
22. Mittal M, Roth M, Konig P, Hofmann S, Dony E, Goyal P, Selbitz AC, Schermuly RT, Ghofrani HA, Kwapiszewska G, et al. Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res 2007;101:258-267.
23. Fink L, Kohlhoff S, Stein MM, Hanze J, Weissmann N, Rose F, Akkayagil E, Manz D, Grimminger F, Seeger W, et al. cDNA array hybridization after laser-assisted microdissection from nonneoplastic tissue. Am J Pathol 2002;160:81-90.
24. + channels of the BK-type in the mouse brain. Histochem Cell Biol 2006;125:725-741.
25. Gietz RD, Woods RA. Genetic transformation of yeast. Biotechniques 2001;30:816-816, 828.
26. Kolonin MG, Zhong J, Finley RL. Interaction mating methods in two-hybrid systems. Methods Enzymol 2000;328:26-46.
27. Gyuris J, Golemis E, Chertkov H, Brent R. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 1993;75:791-803.
28. Waypa GB, Schumacker PT. Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing. J Appl Physiol 2005;98:404-414.
29. Weir EK, Lopez-Barneo J, Buckler KJ, Archer SL. Acute oxygen-sensing mechanisms. N Engl J Med 2005;353:2042-2055.
30. Wolin MS, Ahmad M, Gupte SA. Oxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, and potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol 2005;289:L159-L173.
31. Bonnet S, Michelakis ED, Porter CJ, Andrade-Navarro MA, Thebaud B, Bonnet S, Haromy A, Harry G, Moudgil R, McMurtry MS, et al. An abnormal mitochondrial-hypoxia inducible factor-1α-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension. Circulation 2006;113:2630-2641.
32. 2 sensors, and controversies. News Physiol Sci 2002;17:131-137.
33. Weissmann N, Sommer N, Schermuly RT, Ghofrani HA, Seeger W, Grimminger F. Oxygen sensors in hypoxic pulmonary vasoconstriction. Cardiovasc Res 2006;71:620-629.
34. Vassalli F, Pierre S, Julien V, Bouckaert Y, Brimioulle S, Naeije R. Inhibition of hypoxic pulmonary vasoconstriction by carbon monoxide in dogs. Crit Care Med 2001;29:359-366.
35. Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 2006;99:675-691.
36. Kourembanas S. Hypoxia and carbon monoxide in the vasculature. Antioxid Redox Signal 2002;4:291-299.
37. Christou H, Morita T, Hsieh CM, Koike H, Arkonac B, Perrella MA, Kourembanas S. Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 2000;86:1224-1229.
38. Yun S, Junbao D, Limin G, Chaomei Z, Xiuying T, Chaoshu T. The regulating effect of heme oxygenase/carbon monoxide on hypoxic pulmonary vascular structural remodeling. Biochem Biophys Res Commun 2003;306:523-529.
39. Nachar RA, Pastene CM, Herrera EA, Riquelme RA, Sanhueza EM, Troncoso S, Llanos AJ. Low-dose inhaled carbon monoxide reduces pulmonary vascular resistance during acute hypoxemia in adult sheep. High Alt Med Biol 2001;2:377-385.
40. Zuckerbraun BS, Chin BY, Wegiel B, Billiar TR, Czsimadia E, Rao J, Shimoda L, Ifedigbo E, Kanno S, Otterbein LE. Carbon monoxide reverses established pulmonary hypertension. J Exp Med 2006;203:2109-2119.
41. Carraway MS, Ghio AJ, Suliman HB, Carter JD, Whorton AR, Piantadosi CA. Carbon monoxide promotes hypoxic pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 2002;282:L693-L702.
42. Li YH, Hsieh CY, Wang DL, Chung HC, Liu SL, Chao TH, Shi GY, Wu HL. Remodeling of carotid arteries is associated with increased expression of thrombomodulin in a mouse transverse aortic constriction model. Thromb Haemost 2007;97:658-664.
43. True AL, Olive M, Boehm M, San H, Westrick RJ, Raghavachari N, Xu X, Lynn EG, Sack MN, Munson PJ, et al. Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res 2007;101:893-901.
44. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999;103:129-135.
45. Cacoub P, Karmochkine M, Dorent R, Nataf P, Piette JC, Godeau P, Gandjbakhch I, Boffa MC. Plasma levels of thrombomodulin in pulmonary hypertension. Am J Med 1996;101:160-164.
46. Welsh CH, Hassell KL, Badesch DB, Kressin DC, Marlar RA. Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension. Chest 1996;110:710-717.
47. Sakamaki F, Kyotani S, Nagaya N, Sato N, Oya H, Satoh T, Nakanishi N. Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy. Circulation 2000;102:2720-2725.
48. Sakamaki F, Kyotani S, Nagaya N, Sato N, Oya H, Nakanishi N. Increase in thrombomodulin concentrations after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension. Chest 2003;124:1305-1311.